Search the Newsreel

CrossAmerica schedules investor call for morning after Q2 results

CrossAmerica Partners (NYSE: CAPL) announced its second quarter 2026 earnings results will be released after market close on Wednesday, August 5, 2026. This will be followed by a management-hosted conference call on Thursday, August 6, 2026, at 9:00 a.m. Eastern Time. Investors can access …

CrossAmerica Partners LP to Announce Second Quarter 2026 Earnings Results on August 5

CrossAmerica Partners LP is scheduled to release its second-quarter 2026 earnings results after the market closes on August 5, 2026. A conference call with management will follow on August 6 at 9:00 a.m. Eastern Time. The company, a leading distributor of motor fuels and …

CrossAmerica Partners extends credit agreement maturity to July 2031

CrossAmerica Partners has successfully amended its credit agreement with Citizens Bank, extending the maturity date to July 15, 2031, from the previous March 31, 2028. The amendment also removed the SOFR credit spread adjustment and set new consolidated leverage covenants. Initially, the leverage covenant …

CrossAmerica Partners (NYSE: CAPL) extends loan maturity and revises leverage covenants

CrossAmerica Partners LP has extended the maturity date of its credit facility from March 31, 2028, to July 15, 2031, through a Second Amendment to its Amended and Restated Credit Agreement with Citizens Bank, N.A. The amendment also removes the SOFR credit spread adjustment …

CrossAmerica Partners Extends Credit Facility to 2031, Updates Leverage Covenant

CrossAmerica Partners (CAPL) has extended its Amended and Restated Credit Agreement through a Second Amendment, pushing the maturity date to July 15, 2031. The amendment also revises the financial covenant, setting a maximum Consolidated Leverage Ratio, and aims to enhance the partnership's financial flexibility.

CAPLIPOINT Forecast — Price Target — Prediction for 2027

Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Caplin Point Q4 FY26 Earnings Call Transcript Available

CAPLIPOINT: FY26 revenue up 13.2% and PAT up 20.1%, with robust cash reserves and no debt

Caplin Point Laboratories Submits Q4FY26 SEBI Compliance Certificate

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Share Price Not Quite Adding Up

Caplin Point Labs Q3FY26 Results: Revenue Up 10.1% to ₹542.8 Cr, Earnings Call Audio Now Available

Caplin Point Laboratories Schedules Q3FY26 Earnings Conference Call for February 05, 2026

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Caplin Point Laboratories Ltd. Share Price Live Today

Caplin Point Laboratories' (NSE:CAPLIPOINT) five-year earnings growth trails the strong shareholder returns

Do Caplin Point Laboratories' (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) top holders are insiders and they are likely disappointed by the recent 3.4% drop

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Caplin Point Laboratories Q4 Results